US Life Sciences Market Segmentation
Life Sciences By Drug Class (USD Million, 2025-2035)
- TNF-a inhibitor
- VEGF-A antagonist
Life Sciences By Indication (USD Million, 2025-2035)
- macular degeneration
- diabetic retinopathy
- uveitis
- others
Life Sciences By Distribution Channel (USD Million, 2025-2035)
- hospitals and clinics
- pharmacies
- others